Addex Therapeutics (ADXN) vs Can-Fite Biopharma (CANF)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Can-Fite Biopharma is the larger company by market cap ($6.1 million vs $5.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ADXN | CANF |
|---|---|---|
| Share price | $3.18 | $2.00 |
| Market cap | $5.57M | $6.06M |
| 1-day change | +6.81% | -4.76% |
| YTD return | — | -50.00% |
| 1-year return | — | -83.05% |
| 5-year return | — | -99.35% |
| EPS (TTM) | $-7.56 | $-13.23 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.97 | $12.40 |
| 52-week low | $2.56 | $1.96 |
| Distance from 52-week high | -73.43% | -83.87% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +300.00% |
| Average volume | 138.20K | 388.00K |
| Shares outstanding | 1.75M | 3.03M |
| Employees | 3 | 5 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Addex Therapeutics
ADXN stock →Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
About Can-Fite Biopharma
CANF stock →Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis.
Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees
ADXN vs CANF FAQ
Which is bigger, Addex Therapeutics or Can-Fite Biopharma?
Can-Fite Biopharma (CANF) is larger, with a market capitalization of $6.06M compared with $5.57M for Addex Therapeutics (ADXN).
Are Addex Therapeutics and Can-Fite Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.